Table 7 Results from bio-assays using WHO cone test
Variable | 12 months | 24 months | 36 months |
|---|---|---|---|
Inhambane | N = 30 | N = 30 | N = 30 |
Knock down 60 minutes | |||
Mean (95% CI) | 97.7 % (96.7-98.7) | 88.2 % (86.8-89.7) | 68.3 % (66.2-70.5) |
Median (IQR) | 98.5 % (97.5-99.0) | 89.3 % (86.5-90.5) | 68.4 % (67.9-69.7) |
Mortality 24 hours | |||
Mean (95% CI) | 99.4 % (98.8-99.9) | 97.0 % (98.7-99.9) | 56.7 % (53.4-60.0) |
Median (IQR) | 100 % (99.0-100) | 98.0 % (95.5-98.5) | 55.0 % (52.5-58.5) |
Optimal effectiveness | |||
Estimate (95% CI) | 100 % (–, –) | 100 % (–, –) | 3.3 % (0.4-21.0) |
Minimal effectiveness | |||
Estimate (95% CI) | 100 % (–, –) | 100 % (–, –) | 93.3 % (76.0-98.4) |
Variable | 12 months | 24 months | 36 months |
|---|---|---|---|
Tete | N = 30 | N = 25 | N = 27 |
Knock down 60 minutes | |||
Mean (95% CI) | 99.1 % (98.7-99.6) | 91.2 % (89.8-92.5) | 72.8 % (68.5-77.1) |
Median (IQR) | 100 % (99.0-100) | 89.5 % (87.5-95.5) | 71.5 % (65.7-79.5) |
Mortality 24 hours | |||
Mean (95% CI) | 98.0 % (96.9-99.1) | 97.1 % (95.9-98.3) | 63.8 % (59.7-68.0) |
Median (IQR) | 99.0 % (98.0-100) | 98.0 % (96.0-99.0) | 58.7 % (56.4-67.8) |
Optimal effectiveness | |||
Estimate (95% CI) | 100 % (–, –) | 100 % (–, –) | 11.1 % (3.8-28.4) |
Minimal effectiveness | |||
Estimate (95% CI) | 100 % (–, –) | 100 % (–, –) | 100 % (–, –) |
Variable | 12 months | 24 months | 36 months |
|---|---|---|---|
Nampula | N = 30 | N = 30 | N = 27 |
Knock down 60 minutes | |||
Mean (95% CI) | 98.2 % (97.1-99.3) | 90.8 % (89.8-91.9) | 66.5 % (59.8-73.2) |
Median (IQR) | 98.0 % (98.0-100) | 90.5 % (89.0-93.5) | 57.9 % (52.1-89.5) |
Mortality 24 hours | |||
Mean (95% CI) | 98.8 % (98.4-99.1) | 97.0 % (96.3-97.7) | 68.3 % (60.9-75.8) |
Median (IQR) | 99.0 % (98.0-100) | 97.0 % (96.5-98.0) | 56.7 % (53.3-94.5) |
Optimal effectiveness | |||
Estimate (95% CI) | 100 % (–, –) | 100 % (–, –) | 29.3 % (15.4-49.4) |
Minimal effectiveness | |||
Estimate (95% CI) | 100 % (–, –) | 100 % (–, –) | 96.3 % (77.3-99.5) |